NTDs Causes, Treatments and Preventive Care

POC diagnostics delivers rapid information for patient care. The common platform is the lateral flow immunoassay. Recently, emerging molecular diagnostics have met requirements for speed, low cost, and ease of use for POC applications. A major driver for POC development is the ability to diagnose infectious diseases at sites with limited infrastructure. The potential use in both wealthy and resource-limited settings has fueled an intense effort to build on existing technologies and to generate new technologies for the diagnosis of a broad spectrum of infectious diseases. POC diagnostics also reduce the reliance on presumptive treatment and thereby facilitate antibiotic control. Rapid diagnostic tests work by detecting an analyte that is found in or extracted from clinical samples. There are two primary types of analytes: microbial antigens and patient antibodies that are specific for microbial antigens.  However, there are emerging molecular technologies that enable nucleic acid-based approaches at the POCa

  • Lymphatic Filariasis
  • Onchocerciasis
  • Intestinal Helminths
  • Trachoma
  • New approaches of diagnosis techniques

Related Conference of NTDs Causes, Treatments and Preventive Care

January 21-22, 2021

7th Rare Diseases and Orphan Drugs

Vienna, Austria
February 15-16, 2021

8th International Congress on Infectious Diseases

London, UK
May 10-11, 2021

4th Global Experts Meeting on Infectious Diseases

Singapore City, Singapore
August 16-17, 2021

13th Global Infections Conference

Tokyo, Japan
September 06-07, 2021

11th World Congress on Rare Diseases and Orphan Drugs

Berlin, Germany

NTDs Causes, Treatments and Preventive Care Conference Speakers

Recommended Sessions

Related Journals

Are you interested in